Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
SNM Organization

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 16 December 1988:
Vol. 242. no. 4885, pp. 1528 - 1534
DOI: 10.1126/science.3201241
Prev | Table of Contents | Next

Articles

Science, Vol 242, Issue 4885, 1528-1534
Copyright © 1988 by American Association for the Advancement of Science

articles

Novel regulators of bone formation: molecular clones and activities

JM Wozney, V Rosen, AJ Celeste, LM Mitsock, MJ Whitters, RW Kriz, RM Hewick, and EA Wang

Tissue Growth and Repair Program, Genetics Institute, Inc., Cambridge, MA 02140.

Protein extracts derived from bone can initiate the process that begins with cartilage formation and ends in de novo bone formation. The critical components of this extract, termed bone morphogenetic protein (BMP), that direct cartilage and bone formation as well as the constitutive elements supplied by the animal during this process have long remained unclear. Amino acid sequence has been derived from a highly purified preparation of BMP from bovine bone. Now, human complementary DNA clones corresponding to three polypeptides present in this BMP preparation have been isolated, and expression of the recombinant human proteins have been obtained. Each of the three (BMP-1, BMP-2A, and BMP-3) appears to be independently capable of inducing the formation of cartilage in vivo. Two of the encoded proteins (BMP-2A and BMP-3) are new members of the TGF-beta supergene family, while the third, BMP-1, appears to be a novel regulatory molecule.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Bone Morphogenetic Protein 2 Mediates Dentin Sialophosphoprotein Expression and Odontoblast Differentiation via NF-Y Signaling.
S. Chen, J. Gluhak-Heinrich, M. Martinez, T. Li, Y. Wu, H.-H. Chuang, L. Chen, J. Dong, I. Gay, and M. MacDougall (2008)
J. Biol. Chem. 283, 19359-19370
   Abstract »    Full Text »    PDF »
The cell biology of bone metabolism.
H K Datta, W F Ng, J A Walker, S P Tuck, and S S Varanasi (2008)
J. Clin. Pathol. 61, 577-587
   Abstract »    Full Text »    PDF »
Mesenchyme-dependent BMP signaling directs the timing of mandibular osteogenesis.
A. E. Merrill, B. F. Eames, S. J. Weston, T. Heath, and R. A. Schneider (2008)
Development 135, 1223-1234
   Abstract »    Full Text »    PDF »
Photoencapsulation of Bone Morphogenetic Protein-2 and Periosteal Progenitor Cells Improve Tendon Graft Healing in a Bone Tunnel.
C.-H. Chen, H.-W. Liu, C.-L. Tsai, C.-M. Yu, I-H. Lin, and G.-H. Hsiue (2008)
Am. J. Sports Med. 36, 461-473
   Abstract »    Full Text »    PDF »
Activin A/Bone Morphogenetic Protein (BMP) Chimeras Exhibit BMP-like Activity and Antagonize Activin and Myostatin.
R. V. Korupolu, U. Muenster, J. D. Read, W. Vale, and W. H. Fischer (2008)
J. Biol. Chem. 283, 3782-3790
   Abstract »    Full Text »    PDF »
BMP4 Is Dispensable for Skeletogenesis and Fracture-Healing in the Limb.
K. Tsuji, K. Cox, A. Bandyopadhyay, B. D. Harfe, C. J. Tabin, and V. Rosen (2008)
J. Bone Joint Surg. Am. 90, 14-18
   Abstract »    Full Text »    PDF »
Circulating Bone Marrow-Derived Osteoblast Progenitor Cells Are Recruited to the Bone-Forming Site by the CXCR4/Stromal Cell-Derived Factor-1 Pathway.
S. Otsuru, K. Tamai, T. Yamazaki, H. Yoshikawa, and Y. Kaneda (2008)
Stem Cells 26, 223-234
   Abstract »    Full Text »    PDF »
Osteogenic Gene Expression by Human Periodontal Ligament Cells under Cyclic Tension.
D.C. Wescott, M.N. Pinkerton, B.J. Gaffey, K.T. Beggs, T.J. Milne, and M.C. Meikle (2007)
J. Dent. Res. 86, 1212-1216
   Abstract »    Full Text »    PDF »
BMP signaling regulates the dorsal planarian midline and is needed for asymmetric regeneration.
P. W. Reddien, A. L. Bermange, A. M. Kicza, and A. Sanchez Alvarado (2007)
Development 134, 4043-4051
   Abstract »    Full Text »    PDF »
Activation of the BMP Canonical Signaling Pathway in Human Optic Nerve Head Tissue and Isolated Optic Nerve Head Astrocytes and Lamina Cribrosa Cells.
G. S. Zode, A. F. Clark, and R. J. Wordinger (2007)
Invest. Ophthalmol. Vis. Sci. 48, 5058-5067
   Abstract »    Full Text »    PDF »
Morphogen Receptor Genes and Metamorphogenes: Skeleton Keys to Metamorphosis.
F. S. KAPLAN, J. GROPPE, R. J. PIGNOLO, and E. M. SHORE (2007)
Ann. N.Y. Acad. Sci. 1116, 113-133
   Abstract »    Full Text »    PDF »
TrkC Binds to the Bone Morphogenetic Protein Type II Receptor to Suppress Bone Morphogenetic Protein Signaling.
W. Jin, C. Yun, H.-S. Kim, and S.-J. Kim (2007)
Cancer Res. 67, 9869-9877
   Abstract »    Full Text »    PDF »
Bmp2 Is Critical for the Murine Uterine Decidual Response.
K. Y. Lee, J.-W. Jeong, J. Wang, L. Ma, J. F. Martin, S. Y. Tsai, J. P. Lydon, and F. J. DeMayo (2007)
Mol. Cell. Biol. 27, 5468-5478
   Abstract »    Full Text »    PDF »
Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors.
K. Goto, Y. Kamiya, T. Imamura, K. Miyazono, and K. Miyazawa (2007)
J. Biol. Chem. 282, 20603-20611
   Abstract »    Full Text »    PDF »
Forkhead Proteins Are Critical for Bone Morphogenetic Protein-2 Regulation and Anti-tumor Activity of Resveratrol.
J.-L. Su, C.-Y. Yang, M. Zhao, M.-L. Kuo, and M.-L. Yen (2007)
J. Biol. Chem. 282, 19385-19398
   Abstract »    Full Text »    PDF »
Smad4 is required for maintaining normal murine postnatal bone homeostasis.
X. Tan, T. Weng, J. Zhang, J. Wang, W. Li, H. Wan, Y. Lan, X. Cheng, N. Hou, H. Liu, et al. (2007)
J. Cell Sci. 120, 2162-2170
   Abstract »    Full Text »    PDF »
Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats.
K. Kinoshita, Y. Iimuro, K. Otogawa, S. Saika, Y. Inagaki, Y. Nakajima, N. Kawada, J. Fujimoto, S. L Friedman, and K. Ikeda (2007)
Gut 56, 706-714
   Abstract »    Full Text »    PDF »
Bmp2 Transcription in Osteoblast Progenitors Is Regulated by a Distant 3' Enhancer Located 156.3 Kilobases from the Promoter.
R. L. Chandler, K. J. Chandler, K. A. McFarland, and D. P. Mortlock (2007)
Mol. Cell. Biol. 27, 2934-2951
   Abstract »    Full Text »    PDF »
Management of open fractures and subsequent complications..
C. G. Zalavras, R. E. Marcus, L. S. Levin, and M. J. Patzakis (2007)
J. Bone Joint Surg. Am. 89, 884-895
   Full Text »    PDF »
Effects of Culture Conditions and Bone Morphogenetic Protein 2 on Extent of Chondrogenesis from Human Embryonic Stem Cells.
W. S. Toh, Z. Yang, H. Liu, B. C. Heng, E. H. Lee, and T. Cao (2007)
Stem Cells 25, 950-960
   Abstract »    Full Text »    PDF »
Bone Morphogenetic Protein 1 Prodomain Specifically Binds and Regulates Signaling by Bone Morphogenetic Proteins 2 and 4.
R. Jasuja, G. Ge, N. G. Voss, J. Lyman-Gingerich, A. M. Branam, F. J. Pelegri, and D. S. Greenspan (2007)
J. Biol. Chem. 282, 9053-9062
   Abstract »    Full Text »    PDF »
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
M. Scharpfenecker, M. van Dinther, Z. Liu, R.L. van Bezooijen, Q. Zhao, L. Pukac, C. W. G. M. Lowik, and P. ten Dijke (2007)
J. Cell Sci. 120, 964-972
   Abstract »    Full Text »    PDF »
Effects of TGF-{beta}2, BMP-4, and Gremlin in the Trabecular Meshwork: Implications for Glaucoma.
R. J. Wordinger, D. L. Fleenor, P. E. Hellberg, I.-H. Pang, T. O. Tovar, G. S. Zode, J. A. Fuller, and A. F. Clark (2007)
Invest. Ophthalmol. Vis. Sci. 48, 1191-1200
   Abstract »    Full Text »    PDF »
Bone Graft Substitutes: Separating Fact from Fiction.
R. Sanders (2007)
J. Bone Joint Surg. Am. 89, 469
   Full Text »    PDF »
Bone Grafts and Bone Graft Substitutes in Orthopaedic Trauma Surgery. A Critical Analysis.
W. G. De Long Jr., T. A. Einhorn, K. Koval, M. McKee, W. Smith, R. Sanders, and T. Watson (2007)
J. Bone Joint Surg. Am. 89, 649-658
   Full Text »    PDF »
Hematopoietic Stem-Cell Contribution to Ectopic Skeletogenesis.
F. S. Kaplan, D. L. Glaser, E. M. Shore, R. J. Pignolo, M. Xu, Y. Zhang, D. Senitzer, S. J. Forman, and S. G. Emerson (2007)
J. Bone Joint Surg. Am. 89, 347-357
   Abstract »    Full Text »    PDF »
Pro-inflammatory Cytokine Tumor Necrosis Factor-{alpha} Induces Bone Morphogenetic Protein-2 in Chondrocytes via mRNA Stabilization and Transcriptional Up-regulation.
N. Fukui, Y. Ikeda, T. Ohnuki, A. Hikita, S. Tanaka, S. Yamane, R. Suzuki, L. J. Sandell, and T. Ochi (2006)
J. Biol. Chem. 281, 27229-27241
   Abstract »    Full Text »    PDF »
Bone Morphogenetic Protein-4, a Novel Modulator of Melanogenesis.
M. Yaar, C. Wu, H.-Y. Park, I. Panova, G. Schutz, and B. A. Gilchrest (2006)
J. Biol. Chem. 281, 25307-25314
   Abstract »    Full Text »    PDF »
Heparin Potentiates the in Vivo Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2.
B. Zhao, T. Katagiri, H. Toyoda, T. Takada, T. Yanai, T. Fukuda, U.-i. Chung, T. Koike, K. Takaoka, and R. Kamijo (2006)
J. Biol. Chem. 281, 23246-23253
   Abstract »    Full Text »    PDF »
The zinc finger transcription factor gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling..
M. Zhao, M. Qiao, S. E. Harris, D. Chen, B. O. Oyajobi, and G. R. Mundy (2006)
Mol. Cell. Biol. 26, 6197-6208
   Abstract »    Full Text »    PDF »
Concerted Action of Smad and CREB-binding Protein Regulates Bone Morphogenetic Protein-2-stimulated Osteoblastic Colony-stimulating Factor-1 Expression.
N. Ghosh-Choudhury, P. K. Singha, K. Woodruff, P. S. Clair, S. Bsoul, S. L. Werner, and G. G. Choudhury (2006)
J. Biol. Chem. 281, 20160-20170
   Abstract »    Full Text »    PDF »
Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects. A Randomized, Controlled Trial.
A. L. Jones, R. W. Bucholz, M. J. Bosse, S. K. Mirza, T. R. Lyon, L. X. Webb, A. N. Pollak, J. D. Golden, A. Valentin-Opran, and the BMP-2 Evaluation in Surgery for Tibial Trauma- (2006)
J. Bone Joint Surg. Am. 88, 1431-1441
   Abstract »    Full Text »    PDF »
A Polymorphism in a Conserved Posttranscriptional Regulatory Motif Alters Bone Morphogenetic Protein 2 (BMP2) RNA:Protein Interactions.
D. T. Fritz, S. Jiang, J. Xu, and M. B. Rogers (2006)
Mol. Endocrinol. 20, 1574-1586
   Abstract »    Full Text »    PDF »
Osteoblasts Provide a Suitable Microenvironment for the Action of Receptor Activator of Nuclear Factor-{kappa}B Ligand.
Y. Yamamoto, N. Udagawa, S. Matsuura, Y. Nakamichi, H. Horiuchi, A. Hosoya, M. Nakamura, H. Ozawa, K. Takaoka, J. M. Penninger, et al. (2006)
Endocrinology 147, 3366-3374
   Abstract »    Full Text »    PDF »
Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation.
E.-J. Jeon, K.-Y. Lee, N.-S. Choi, M.-H. Lee, H.-N. Kim, Y.-H. Jin, H.-M. Ryoo, J.-Y. Choi, M. Yoshida, N. Nishino, et al. (2006)
J. Biol. Chem. 281, 16502-16511
   Abstract »    Full Text »    PDF »
Recombinant Human Bone Morphogenetic Protein-2 in Open Tibial Fractures. A Subgroup Analysis of Data Combined from Two Prospective Randomized Studies.
M. F. Swiontkowski, H. T. Aro, S. Donell, J. L. Esterhai, J. Goulet, A. Jones, P. J. Kregor, L. Nordsletten, G. Paiement, and A. Patel (2006)
J. Bone Joint Surg. Am. 88, 1258-1265
   Abstract »    Full Text »    PDF »
CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells.
W. Si, Q. Kang, H. H. Luu, J. K. Park, Q. Luo, W.-X. Song, W. Jiang, X. Luo, X. Li, H. Yin, et al. (2006)
Mol. Cell. Biol. 26, 2955-2964
   Abstract »    Full Text »    PDF »
Regulating Bone Growth and Development with Bone Morphogenetic Proteins.
P. S. LEBOY (2006)
Ann. N.Y. Acad. Sci. 1068, 14-18
   Abstract »    Full Text »    PDF »
BMP and BMP Inhibitors in Bone.
V. ROSEN (2006)
Ann. N.Y. Acad. Sci. 1068, 19-25
   Abstract »    Full Text »    PDF »
BMP Signaling and Skeletogenesis.
X. LI and X. CAO (2006)
Ann. N.Y. Acad. Sci. 1068, 26-40
   Abstract »    Full Text »    PDF »
Dysregulation of the BMP-4 Signaling Pathway in Fibrodysplasia Ossificans Progressiva.
F. S. KAPLAN, J. FIORI, L. S. DE LA PENA, J. AHN, P. C. BILLINGS, and E. M. SHORE (2006)
Ann. N.Y. Acad. Sci. 1068, 54-65
   Abstract »    Full Text »    PDF »
Additive Enhancement of Implant Fixation Following Combined Treatment with rhTGF-beta2 and rhBMP-2 in a Canine Model.
D.R. Sumner, T.M. Turner, R.M. Urban, A.S. Virdi, and N. Inoue (2006)
J. Bone Joint Surg. Am. 88, 806-817
   Abstract »    Full Text »    PDF »
Assessing Self-Renewal and Differentiation in Human Embryonic Stem Cell Lines.
J. Cai, J. Chen, Y. Liu, T. Miura, Y. Luo, J. F. Loring, W. J. Freed, M. S. Rao, and X. Zeng (2006)
Stem Cells 24, 516-530
   Abstract »    Full Text »    PDF »
Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension.
H. Takahashi, N. Goto, Y. Kojima, Y. Tsuda, Y. Morio, M. Muramatsu, and Y. Fukuchi (2006)
Am J Physiol Lung Cell Mol Physiol 290, L450-L458
   Abstract »    Full Text »    PDF »
HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
R. L. Caldwell, R. Gadipatti, K. B. Lane, and V. L. Shepherd (2006)
J. Leukoc. Biol. 79, 192-201
   Abstract »    Full Text »    PDF »
Bone Morphogenetic Protein-2-Induced Transformation Involves the Activation of Mammalian Target of Rapamycin.
E. M. Langenfeld, Y. Kong, and J. Langenfeld (2005)
Mol. Cancer Res. 3, 679-684
   Abstract »    Full Text »    PDF »
Involvement of Endogenous Bone Morphogenetic Protein (BMP) 2 and BMP6 in Bone Formation.
F. Kugimiya, H. Kawaguchi, S. Kamekura, H. Chikuda, S. Ohba, F. Yano, N. Ogata, T. Katagiri, Y. Harada, Y. Azuma, et al. (2005)
J. Biol. Chem. 280, 35704-35712
   Abstract »    Full Text »    PDF »
Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas.
E. M. Langenfeld, J. Bojnowski, J. Perone, and J. Langenfeld (2005)
Ann. Thorac. Surg. 80, 1028-1032
   Abstract »    Full Text »    PDF »
Platelet-Derived Growth Factor Inhibits Demineralized Bone Matrix-Induced Intramuscular Cartilage and Bone Formation. A Study of Immunocompromised Mice.
D. M. Ranly, J. McMillan, T. Keller, C. H. Lohmann, T. Meunch, D. L. Cochran, Z. Schwartz, and B. D. Boyan (2005)
J. Bone Joint Surg. Am. 87, 2052-2064
   Abstract »    Full Text »    PDF »
Localization and Action of Dragon (Repulsive Guidance Molecule b), a Novel Bone Morphogenetic Protein Coreceptor, throughout the Reproductive Axis.
Y. Xia, Y. Sidis, A. Mukherjee, T. A. Samad, G. Brenner, C. J. Woolf, H. Y. Lin, and A. Schneyer (2005)
Endocrinology 146, 3614-3621
   Abstract »    Full Text »    PDF »
Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice.
Y. Song, J. E. Jones, H. Beppu, J. F. Keaney Jr, J. Loscalzo, and Y.-Y. Zhang (2005)
Circulation 112, 553-562
   Abstract »    Full Text »    PDF »
Identification of the Minimal Domain Structure of Bone Morphogenetic Protein-1 (BMP-1) for Chordinase Activity: CHORDINASE ACTIVITY IS NOT ENHANCED BY PROCOLLAGEN C-PROTEINASE ENHANCER-1 (PCPE-1).
V. Petropoulou, L. Garrigue-Antar, and K. E. Kadler (2005)
J. Biol. Chem. 280, 22616-22623
   Abstract »    Full Text »    PDF »
Enamel Matrix Derivative Gel Stimulates Signal Transduction of BMP and TGF-{beta}.
S. Suzuki, T. Nagano, Y. Yamakoshi, K. Gomi, T. Arai, M. Fukae, T. Katagiri, and S. Oida (2005)
J. Dent. Res. 84, 510-514
   Abstract »    Full Text »    PDF »
Smad1 and Smad8 Function Similarly in Mammalian Central Nervous System Development.
M. Hester, J. C. Thompson, J. Mills, Y. Liu, H. M. El-Hodiri, and M. Weinstein (2005)
Mol. Cell. Biol. 25, 4683-4692
   Abstract »    Full Text »    PDF »
Bone Morphogenetic Proteins. Development and Clinical Efficacy in the Treatment of Fractures and Bone Defects.
M.F. Termaat, F.C. Den Boer, F.C. Bakker, P. Patka, and H.J.Th.M. Haarman (2005)
J. Bone Joint Surg. Am. 87, 1367-1378
   Abstract »    Full Text »    PDF »
Matching catalytic activity to developmental function: Tolloid-related processes Sog in order to help specify the posterior crossvein in the Drosophila wing.
M. Serpe, A. Ralston, S. S. Blair, and M. B. O'Connor (2005)
Development 132, 2645-2656
   Abstract »    Full Text »    PDF »
Differences in Gene Expression between Wild Type and Hoxa1 Knockout Embryonic Stem Cells after Retinoic Acid Treatment or Leukemia Inhibitory Factor (LIF) Removal.
E. Martinez-Ceballos, P. Chambon, and L. J. Gudas (2005)
J. Biol. Chem. 280, 16484-16498
   Abstract »    Full Text »    PDF »
Gene expression profiles in HEK-293 cells with low or high store-operated calcium entry: can regulatory as well as regulated genes be identified?.
T. K. Zagranichnaya, X. Wu, A. M. Danos, and M. L. Villereal (2005)
Physiol Genomics 21, 14-33
   Abstract »    Full Text »    PDF »
Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells.
Q. Luo, Q. Kang, W. Si, W. Jiang, J. K. Park, Y. Peng, X. Li, H. H. Luu, J. Luo, A. G. Montag, et al. (2004)
J. Biol. Chem. 279, 55958-55968
   Abstract »    Full Text »    PDF »
Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of Chordin.
R. Jasuja, B. L. Allen, W. N. Pappano, A. C. Rapraeger, and D. S. Greenspan (2004)
J. Biol. Chem. 279, 51289-51297
   Abstract »    Full Text »    PDF »
Deletion of Epidermal Growth Factor-like Domains Converts Mammalian Tolloid into a Chordinase and Effective Procollagen C-proteinase.
L. Garrigue-Antar, V. Francois, and K. E. Kadler (2004)
J. Biol. Chem. 279, 49835-49841
   Abstract »    Full Text »    PDF »
Conservation of Bmp2 Post-transcriptional Regulatory Mechanisms.
D. T. Fritz, D. Liu, J. Xu, S. Jiang, and M. B. Rogers (2004)
J. Biol. Chem. 279, 48950-48958
   Abstract »    Full Text »    PDF »
Signal Pathways in Up-regulation of Chemokines by Tyrosine Kinase MER/NYK in Prostate Cancer Cells.
Y.-M. Wu, D. R. Robinson, and H.-J. Kung (2004)
Cancer Res. 64, 7311-7320
   Abstract »    Full Text »    PDF »
Restoration of Bone Morphogenetic Protein Receptor Type II Expression Leads to a Decreased Rate of Tumor Growth in Bladder Transitional Cell Carcinoma Cell Line TSU-Pr1.
I. Y. Kim, D.-H. Lee, D. K. Lee, W. J. Kim, M. M. Kim, R. A. Morton, S. P. Lerner, and S. J. Kim (2004)
Cancer Res. 64, 7355-7360
   Abstract »    Full Text »    PDF »
Processing and Transport of Matrix {gamma}-Carboxyglutamic Acid Protein and Bone Morphogenetic Protein-2 in Cultured Human Vascular Smooth Muscle Cells: EVIDENCE FOR AN UPTAKE MECHANISM FOR SERUM FETUIN.
N. Wajih, T. Borras, W. Xue, S. M. Hutson, and R. Wallin (2004)
J. Biol. Chem. 279, 43052-43060
   Abstract »    Full Text »    PDF »
Menin Is Required for Bone Morphogenetic Protein 2- and Transforming Growth Factor {beta}-regulated Osteoblastic Differentiation through Interaction with Smads and Runx2.
H. Sowa, H. Kaji, G. N. Hendy, L. Canaff, T. Komori, T. Sugimoto, and K. Chihara (2004)
J. Biol. Chem. 279, 40267-40275
   Abstract »    Full Text »    PDF »
Transient Changes in Oxygen Tension Inhibit Osteogenic Differentiation and Runx2 Expression in Osteoblasts.
A. Salim, R. P. Nacamuli, E. F. Morgan, A. J. Giaccia, and M. T. Longaker (2004)
J. Biol. Chem. 279, 40007-40016
   Abstract »    Full Text »    PDF »
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification.
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth (2004)
Endocr. Rev. 25, 629-672
   Abstract »    Full Text »    PDF »
Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells.
Y. Peng, Q. Kang, Q. Luo, W. Jiang, W. Si, B. A. Liu, H. H. Luu, J. K. Park, X. Li, J. Luo, et al. (2004)
J. Biol. Chem. 279, 32941-32949
   Abstract »    Full Text »    PDF »
An Evolutionary and Molecular Analysis of Bmp2 Expression.
K. L. Abrams, J. Xu, C. Nativelle-Serpentini, S. Dabirshahsahebi, and M. B. Rogers (2004)
J. Biol. Chem. 279, 15916-15928
   Abstract »    Full Text »    PDF »
Smurf1 Inhibits Osteoblast Differentiation and Bone Formation in Vitro and in Vivo.
M. Zhao, M. Qiao, S. E. Harris, B. O. Oyajobi, G. R. Mundy, and D. Chen (2004)
J. Biol. Chem. 279, 12854-12859
   Abstract »    Full Text »    PDF »
Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton.
F. Long, U.-i. Chung, S. Ohba, J. McMahon, H. M. Kronenberg, and A. P. McMahon (2004)
Development 131, 1309-1318
   Abstract »    Full Text »    PDF »
Bone Morphogenetic Protein-2 Stimulates Angiogenesis in Developing Tumors.
E. M. Langenfeld and J. Langenfeld (2004)
Mol. Cancer Res. 2, 141-149
   Abstract »    Full Text »    PDF »
Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling.
A. V. Finsen, P. R. Woldbaek, J. Li, J. Wu, T. Lyberg, T. Tonnessen, and G. Christensen (2004)
Physiol Genomics 16, 301-308
   Abstract »    Full Text »    PDF »
The Bone Morphogenetic Protein System In Mammalian Reproduction.
S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson (2004)
Endocr. Rev. 25, 72-101
   Abstract »    Full Text »    PDF »
Virus-Host Cell Interactions during Hepatitis C Virus RNA Replication: Impact of Polyprotein Expression on the Cellular Transcriptome and Cell Cycle Association with Viral RNA Synthesis.
F. Scholle, K. Li, F. Bodola, M. Ikeda, B. A. Luxon, and S. M. Lemon (2004)
J. Virol. 78, 1513-1524
   Abstract »    Full Text »    PDF »
Bone Morphogenetic Protein-1/Tolloid-like Proteinases Process Dentin Matrix Protein-1.
B. M. Steiglitz, M. Ayala, K. Narayanan, A. George, and D. S. Greenspan (2004)
J. Biol. Chem. 279, 980-986
   Abstract »    Full Text »    PDF »
Decreased Expression of Bone Morphogenetic Protein (BMP) Receptor Type II Correlates with Insensitivity to BMP-6 in Human Renal Cell Carcinoma Cells.
I. Y. Kim, D.-H. Lee, D. K. Lee, B. C. Kim, H. T. Kim, F. S. Leach, W. M. Linehan, R. A. Morton, and S. J. Kim (2003)
Clin. Cancer Res. 9, 6046-6051
   Abstract »    Full Text »    PDF »
Brief Bone Morphogenetic Protein 2 Treatment of Glucocorticoid-inhibited MC3T3-E1 Osteoblasts Rescues Commitment-associated Cell Cycle and Mineralization without Alteration of Runx2.
C. A. Luppen, N. Leclerc, T. Noh, A. Barski, A. Khokhar, A. L. Boskey, E. Smith, and B. Frenkel (2003)
J. Biol. Chem. 278, 44995-45003
   Abstract »    Full Text »    PDF »
Sulfated Polysaccharides Enhance the Biological Activities of Bone Morphogenetic Proteins.
T. Takada, T. Katagiri, M. Ifuku, N. Morimura, M. Kobayashi, K. Hasegawa, A. Ogamo, and R. Kamijo (2003)
J. Biol. Chem. 278, 43229-43235
   Abstract »    Full Text »    PDF »
The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells.
E. M. Langenfeld, S. E. Calvano, F. Abou-Nukta, S. F. Lowry, P. Amenta, and J. Langenfeld (2003)
Carcinogenesis 24, 1445-1454
   Abstract »    Full Text »    PDF »
A Single Percutaneous Injection of Recombinant Human Bone Morphogenetic Protein-2 Accelerates Fracture Repair.
T. A. Einhorn, R. J Majeska, A. Mohaideen, E. M. Kagel, M. L. Bouxsein, T. J. Turek, and J. M. Wozney (2003)
J. Bone Joint Surg. Am. 85, 1425-1435
   Abstract »    Full Text »    PDF »
Osteogenic Activity of the Fourteen Types of Human Bone Morphogenetic Proteins (BMPs).
H. Cheng, W. Jiang, F. M. Phillips, R. C. Haydon, Y. Peng, L. Zhou, H. H. Luu, N. An, B. Breyer, P. Vanichakarn, et al. (2003)
J. Bone Joint Surg. Am. 85, 1544-1552
   Abstract »    Full Text »    PDF »
Marshall R. Urist: A Renaissance Scientist and Orthopaedic Surgeon.
A. H. Reddi (2003)
J. Bone Joint Surg. Am. 85, 3-7
   Full Text »    PDF »
Signal Transduction of Bone Morphogenetic Proteins in Osteoblast Differentiation.
P. t. Dijke, J. Fu, P. Schaap, and B. A.J. Roelen (2003)
J. Bone Joint Surg. Am. 85, 34-38
   Full Text »    PDF »
Clinical Applications of Recombinant Human BMPs: Early Experience and Future Development.
T. A. Einhorn (2003)
J. Bone Joint Surg. Am. 85, 82-88
   Full Text »    PDF »
Use of Bmp1/Tll1 Doubly Homozygous Null Mice and Proteomics To Identify and Validate In Vivo Substrates of Bone Morphogenetic Protein 1/Tolloid-Like Metalloproteinases.<